| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |